Cyclopenthiazide

Cyclopenthiazide

Specific Antihypertensive Drugs

Published in Julian Tudor Hart, Hypertension, 2018

Despite academic consensus on low dosage, review of the formulations actually available, generic or branded, shows that obsolete production, marketing, and practice continue almost unchanged. The smallest available tablets are 2.5 mg for bendrofluazide and 50 mg for chlorthalidone, twice the fully effective dosage for blood pressure control. Cyclopenthiazide (Navidrex) is still available only as 500 μg, 3 years after published research showed that this was four times the optimal dose.

Drug profiles: generic names A–Z

View Chapter

Purchase Book

Published in Jerome Z. Litt, Neil H. Shear, Litt's Drug Eruption & Reaction Manual, 2017

Jerome Z. Litt, Neil H. Shear

Clinically important, potentially hazardous interactions with: acebutolol, alfuzosin, bromocriptine, captopril, cilazapril, cyclopenthiazide, diclofenac, enalapril, ephedrine, fosinopril, irbesartan, levodopa, levomepromazine, linezolid, lisinopril, meloxicam, olmesartan, quinapril, ramipril, risperidone, rotigotine, trandolapril, triamcinolone, zuclopenthixol

Choosing among second-generation antidepressant treatments for depressed patients with cardiac diseases

View Article

Journal Information

Published in International Journal of Psychiatry in Clinical Practice, 2019

Siegfried Kasper

Diuretics (e.g., indapamide, bendroflumethiazide, chlorthalidone, metolazone, cyclopenthiazide, furosemide, torsemide, bumetanide) are recommended as first-line therapy for hypertension and HF (Shah, Anjum, & Littler, 2004a; 2004b). Based on the available clinical data, diuretic-based therapy has been clearly documented to reduce cardiovascular morbidity and mortality, and thiazide-type diuretics are recommended for the treatment of elderly hypertensive patients (Kaplan, 2004).

Explore chapters and articles related to this topic

Specific Antihypertensive Drugs

Drug profiles: generic names A–Z

Choosing among second-generation antidepressant treatments for depressed patients with cardiac diseases